Application 087562
- Type
- ANDA
- Sponsor
- IDT AUSTRALIA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DIPYRIDAMOLE | DIPYRIDAMOLE | TABLET;ORAL | 50MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dipyridamole | DIPYRIDAMOLE | Hikma Pharmaceuticals USA Inc. | 6093dcd9-82d2-414f-8507-eda22c14f626 | 2026-05-20 | Warnings, Adverse reactions | Dipyridamole DIPYRIDAMOLE |
| Dipyridamole | DIPYRIDAMOLE | REMEDYREPACK INC. | 226099e2-70bb-4b9b-bb52-c20fbca2aec5 | 2026-04-29 | Adverse reactions | Dipyridamole DIPYRIDAMOLE |
| Dipyridamole | DIPYRIDAMOLE | Amneal Pharmaceuticals of New York LLC | a18b2af5-7c4a-4b7f-92c7-8a76e34da373 | 2026-04-15 | Adverse reactions | Dipyridamole DIPYRIDAMOLE |
| Dipyridamole | DIPYRIDAMOLE | Henry Schein, Inc. | 1a2c0a9a-c637-4485-ad4b-0b6d0b05fa20 | 2025-10-30 | Warnings, Adverse reactions | Dipyridamole DIPYRIDAMOLE |
| DIPYRIDAMOLE | DIPYRIDAMOLE | HF Acquisition Co LLC, DBA HealthFirst | 9bd34108-9d98-c4ca-e053-2995a90a2bc8 | 2025-01-08 | Warnings, Adverse reactions | DIPYRIDAMOLE DIPYRIDAMOLE |
| Dipyridamole | DIPYRIDAMOLE | Zydus Lifesciences Limited | 312aadb1-435c-4aa7-8e46-6506cedacaa0 | 2024-11-26 | Dipyridamole DIPYRIDAMOLE | |
| Dipyridamole | DIPYRIDAMOLE | Zydus Pharmaceuticals USA Inc. | 004bada0-dbf7-4a94-8792-6833d7eeda2b | 2023-09-16 | Adverse reactions | Dipyridamole DIPYRIDAMOLE |
| Dipyridamole | DIPYRIDAMOLE | Oxford Pharmaceuticals, LLC | f7ffd78a-e93a-40f4-8193-2d6ab4dafd00 | 2021-03-29 | Adverse reactions | Dipyridamole DIPYRIDAMOLE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.